Cargando…
Evaluation of ROTARIX(®) Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
Oral rotavirus vaccines show diminished immunogenicity in low-resource settings where rotavirus burden is highest. This study assessed the safety and immune boosting effect of a third dose of oral ROTARIX(®) (GlaxoSmithKline) vaccine administered at 9 months of age. A total of 214 infants aged 6 to...
Autores principales: | Laban, Natasha Makabilo, Bosomprah, Samuel, Simuyandi, Michelo, Chibuye, Mwelwa, Chauwa, Adriace, Chirwa-Chobe, Masuzyo, Sukwa, Nsofwa, Chipeta, Chikumbutso, Velu, Rachel, Njekwa, Katanekwa, Mubanga, Cynthia, Mwape, Innocent, Goodier, Martin Rhys, Chilengi, Roma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960729/ https://www.ncbi.nlm.nih.gov/pubmed/36851224 http://dx.doi.org/10.3390/vaccines11020346 |
Ejemplares similares
-
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix(TM)) Immunogenicity among Infants in Zambia
por: Chauwa, Adriace, et al.
Publicado: (2023) -
Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017) -
Development of a diarrhoea severity scoring scale in a passive health facility-based surveillance system
por: St Jean, Denise T., et al.
Publicado: (2022) -
Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia
por: Mwila-Kazimbaya, Katayi, et al.
Publicado: (2017) -
Clinical presentation of congenital syphilis in a rotavirus vaccine cohort study in Lusaka: a case series
por: Sukwa, Nsofwa, et al.
Publicado: (2021)